153 related articles for article (PubMed ID: 37140813)
21. miR-375-3p suppresses tumorigenesis and partially reverses chemoresistance by targeting YAP1 and SP1 in colorectal cancer cells.
Xu X; Chen X; Xu M; Liu X; Pan B; Qin J; Xu T; Zeng K; Pan Y; He B; Sun H; Sun L; Wang S
Aging (Albany NY); 2019 Sep; 11(18):7357-7385. PubMed ID: 31543507
[TBL] [Abstract][Full Text] [Related]
22. NKX6.1 Represses Tumorigenesis, Metastasis, and Chemoresistance in Colorectal Cancer.
Chung HH; Lee CT; Hu JM; Chou YC; Lin YW; Shih YL
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707737
[TBL] [Abstract][Full Text] [Related]
23. The Plasma microRNA miR-1914* and -1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-regulating NFIX.
Hu J; Cai G; Xu Y; Cai S
Curr Mol Med; 2016; 16(1):70-82. PubMed ID: 26695693
[TBL] [Abstract][Full Text] [Related]
24. Transcription factor B-MYB activates lncRNA CCAT1 and upregulates SOCS3 to promote chemoresistance in colorectal cancer.
Liu F; Wang Y; Cao Y; Wu Z; Ma D; Cai J; Sha J; Chen Q
Chem Biol Interact; 2023 Apr; 374():110412. PubMed ID: 36812959
[TBL] [Abstract][Full Text] [Related]
25. MiR-744 mediates the Oxaliplatin chemoresistance in colorectal cancer through inhibiting BIN1.
Zhou Y; He A; Zhang L; Yi G
Neoplasma; 2020 Mar; 67(2):296-303. PubMed ID: 31884801
[TBL] [Abstract][Full Text] [Related]
26. ERCC1 and XPD/ERCC2 polymorphisms' predictive value of oxaliplatin-based chemotherapies in advanced colorectal cancer has an ethnic discrepancy: a meta-analysis.
Lu X; Xiao S; Jin C; van der Straaten T; Li X
J Clin Lab Anal; 2012 Jan; 26(1):10-5. PubMed ID: 24833529
[TBL] [Abstract][Full Text] [Related]
27. Regulation of ATP-binding cassette subfamily B member 1 by Snail contributes to chemoresistance in colorectal cancer.
Wang H; Li JM; Wei W; Yang R; Chen D; Ma XD; Jiang GM; Wang BL
Cancer Sci; 2020 Jan; 111(1):84-97. PubMed ID: 31774615
[TBL] [Abstract][Full Text] [Related]
28. Hedgehog-GLI signalling promotes chemoresistance through the regulation of ABC transporters in colorectal cancer cells.
Po A; Citarella A; Catanzaro G; Besharat ZM; Trocchianesi S; Gianno F; Sabato C; Moretti M; De Smaele E; Vacca A; Fiori ME; Ferretti E
Sci Rep; 2020 Aug; 10(1):13988. PubMed ID: 32814794
[TBL] [Abstract][Full Text] [Related]
29. Thiol oxidative stress-dependent degradation of transglutaminase2 via protein S-glutathionylation sensitizes 5-fluorouracil therapy in 5-fluorouracil-resistant colorectal cancer cells.
Li X; Ma Y; Wu J; Ni M; Chen A; Zhou Y; Dai W; Chen Z; Jiang R; Ling Y; Yao Q; Chen W
Drug Resist Updat; 2023 Mar; 67():100930. PubMed ID: 36736043
[TBL] [Abstract][Full Text] [Related]
30. MIR600HG suppresses metastasis and enhances oxaliplatin chemosensitivity by targeting ALDH1A3 in colorectal cancer.
Yao Y; Li N
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32270866
[TBL] [Abstract][Full Text] [Related]
31. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
[TBL] [Abstract][Full Text] [Related]
32. ANRIL promotes chemoresistance via disturbing expression of ABCC1 by regulating the expression of Let-7a in colorectal cancer.
Zhang Z; Feng L; Liu P; Duan W
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30279206
[TBL] [Abstract][Full Text] [Related]
33. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.
Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X
Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999
[TBL] [Abstract][Full Text] [Related]
34. Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin.
Bommer UA; Vine KL; Puri P; Engel M; Belfiore L; Fildes K; Batterham M; Lochhead A; Aghmesheh M
Cell Commun Signal; 2017 Feb; 15(1):9. PubMed ID: 28143584
[TBL] [Abstract][Full Text] [Related]
35. Prostaglandin F
Wang YJ; Xie XL; Liu HQ; Tian H; Jiang XY; Zhang JN; Chen SX; Liu T; Wang SL; Zhou X; Jin XX; Liu SM; Jiang HQ
World J Gastroenterol; 2023 Oct; 29(39):5452-5470. PubMed ID: 37900995
[TBL] [Abstract][Full Text] [Related]
36. CAF-derived exosomal lncRNA FAL1 promotes chemoresistance to oxaliplatin by regulating autophagy in colorectal cancer.
Zhu S; Mao J; Zhang X; Wang P; Zhou Y; Tong J; Peng H; Yang B; Fu Q
Dig Liver Dis; 2024 Feb; 56(2):330-342. PubMed ID: 37400281
[TBL] [Abstract][Full Text] [Related]
37. Nucleoside diphosphate kinase 2 confers acquired 5-fluorouracil resistance in colorectal cancer cells.
Wen S; Wang X; Wang Y; Shen J; Pu J; Liang H; Chen C; Liu L; Dai P
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):896-905. PubMed ID: 29475390
[TBL] [Abstract][Full Text] [Related]
38. An association of selected ERCC2 and ERCC5 genes polymorphisms, the level of oxidative DNA damage and its repair efficiency with a risk of colorectal cancer in Polish population.
Kabzinski J; Przybylowska K; Dziki L; Dziki A; Majsterek I
Cancer Biomark; 2015; 15(4):413-23. PubMed ID: 25835182
[TBL] [Abstract][Full Text] [Related]
39. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
[TBL] [Abstract][Full Text] [Related]
40. Wnt/β-catenin signalling activates IMPDH2-mediated purine metabolism to facilitate oxaliplatin resistance by inhibiting caspase-dependent apoptosis in colorectal cancer.
Huang Y; Chan S; Chen S; Liu X; Li M; Zheng L; Dong Z; Yang Z; Liu Z; Zhou D; Zhang X; Zhang B
J Transl Med; 2024 Feb; 22(1):133. PubMed ID: 38310229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]